Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosinter Restaurants Holding reported for 2023 according by RAS

4/2/24 ROST

VHZ reported for 2023 by RAS

4/2/24 VLHZ

Moscow Exchange summarized the results of trading in March

4/2/24 MOEX

Kamaz reported for 2023 by IFRS

4/2/24 KMAZ

Astra may acquire two cloud service providers

4/2/24 ASTR

SGC reported for 2023 by RAS

4/2/24 UGLD

Zaimer plans to open a collection agency

4/2/24 ZAYM

General Director of PIK became Yervand Karapetyan

4/2/24 PIKK

Samaraenergo reported for 2023 by RAS

4/2/24 SAGO

Fesco reports for 2023 by RAS

4/2/24 FESH